Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rode

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
BMC Endocrine Disorders|February 27, 2010
The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in periodPeter Weeke, Charlotte Andersson, Emil L Fosbøl, et al.
Journal of the Royal Society, Interface|July 20, 2006
Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patientsN M Ferguson, C A Donnelly, J Hooper, et al.
HIV Medicine|May 7, 2005
Gender difference in HIV-1 RNA viral loadsC A Donnelly, L M Bartley, A C Ghani, et al.
The New England Journal of Medicine|September 8, 2010
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjectsW Philip T James, Ian D Caterson, Walmir Coutinho, et al.
HIV Clinical Trials|January 2, 2007
Substitution with lopinavir/ritonavir improves patient-reported outcomes including quality of life in patients who were intolerant to their antiretroviral therapyEduardo Sprinz, Andrade J Neto, Eduardo Bargman, et al.
Metabolism: Clinical and Experimental|May 21, 2009
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trialCharlotte Andersson, Peter Weeke, Emil Loldrup Fosbøl, et al.
Gut Microbes|March 29, 2021
Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatmentKang Kang, Lejla Imamovic, Maria-Anna Misiakou, et al.
The Journal of Infectious Diseases|June 26, 2009
Predictive value of HIV-1 genotypic resistance test interpretation algorithmsSoo-Yon Rhee, W Jeffrey Fessel, Tommy F Liu, et al.
AIDS (London, England)|September 22, 2006
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral useGrace P S Kwong, Azra C Ghani, Richard A Rode, et al.
The Journal of Biological Chemistry|May 20, 2016
Mediator, TATA-binding protein, and RNA polymerase II contribute to low histone occupancy at active gene promoters in yeastSuraiya A Ansari, Emily Paul, Sebastian Sommer, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
BMC Endocrine Disorders|February 27, 2010
The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in periodPeter Weeke, Charlotte Andersson, Emil L Fosbøl, et al.
Journal of the Royal Society, Interface|July 20, 2006
Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patientsN M Ferguson, C A Donnelly, J Hooper, et al.
HIV Medicine|May 7, 2005
Gender difference in HIV-1 RNA viral loadsC A Donnelly, L M Bartley, A C Ghani, et al.
The New England Journal of Medicine|September 8, 2010
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjectsW Philip T James, Ian D Caterson, Walmir Coutinho, et al.
HIV Clinical Trials|January 2, 2007
Substitution with lopinavir/ritonavir improves patient-reported outcomes including quality of life in patients who were intolerant to their antiretroviral therapyEduardo Sprinz, Andrade J Neto, Eduardo Bargman, et al.
Metabolism: Clinical and Experimental|May 21, 2009
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trialCharlotte Andersson, Peter Weeke, Emil Loldrup Fosbøl, et al.
Gut Microbes|March 29, 2021
Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatmentKang Kang, Lejla Imamovic, Maria-Anna Misiakou, et al.
The Journal of Infectious Diseases|June 26, 2009
Predictive value of HIV-1 genotypic resistance test interpretation algorithmsSoo-Yon Rhee, W Jeffrey Fessel, Tommy F Liu, et al.
AIDS (London, England)|September 22, 2006
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral useGrace P S Kwong, Azra C Ghani, Richard A Rode, et al.
The Journal of Biological Chemistry|May 20, 2016
Mediator, TATA-binding protein, and RNA polymerase II contribute to low histone occupancy at active gene promoters in yeastSuraiya A Ansari, Emily Paul, Sebastian Sommer, et al.
Pageof 18